Mobile Site ›
Print Friendly View

Test ID: APO1K    
Apolipoprotein A-I (APOA1) Gene, Known Mutation

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Testing of individuals at risk for apolipoprotein A-I (APOA1) gene-associated amyloidosis when a mutation has been identified in an affected family member

Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request

Documentation of the specific familial mutation(s) must be provided with the specimen in order to perform this test.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) Followed by DNA Sequence Analysis

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

APOA1 Gene, Known Mutation

Aliases Lists additional common names for a test, as an aid in searching

APOA1
APOAI
Apolipoprotein A-I
Amyloidosis